Click here to know more about our subscription packages.
Want to commission a custom market research to suit your needs? We are here to help. Let us know.
As per NAVADHI Market Research, the global pharmaceutical industry will we worth USD 1.57 trillion by 2023.
Bayer is a German multinational pharmaceutical and life sciences company with a more than 150-year history and core competencies in the areas of health care and agriculture, is one of the largest pharmaceutical companies in the world.
Company’s innovative products are contributing to finding solutions to some of the major challenges of recent time. Bayer's main goal is to create value for their customers, stockholders and employees, while also strengthening the company’s financials.
Revenues at the Pharmaceuticals segment increased 1.8% to €4,291 million in the fourth quarter. Growth was backed by consistent strong performance of key products like Xarelto, Eylea, Xofigo, Stivarga and Adempas. Strongest sales growth among the other top Pharmaceuticals products was recorded for the diabetes treatment Glucobay, driven by expanded volumes in China.
Bayer's core earnings came down to USD 1.75 per share in 2018 compared with earnings of USD 1.87 in 2017. Earnings have beaten the Zacks Consensus Estimate of USD1.63.
Bayer's revenue in 2018 stands at €39.58 Billion, up from €35.01 billion in 2017.
Spanning over 35 pages and 17 exhibits, “Bayer AG - Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for Bayer AG.
Do you need more information about this report before making a purchase decision or wish to customize this report to suite your requirements?
If yes, then please use the form given below and we will get in touch with you immediately.
Kindly use your official email address and contact number to ensure speedy response.
View all our market research reports